289 related articles for article (PubMed ID: 24255918)
1. Polyphosphate amplifies proinflammatory responses of nuclear proteins through interaction with receptor for advanced glycation end products and P2Y1 purinergic receptor.
Dinarvand P; Hassanian SM; Qureshi SH; Manithody C; Eissenberg JC; Yang L; Rezaie AR
Blood; 2014 Feb; 123(6):935-45. PubMed ID: 24255918
[TBL] [Abstract][Full Text] [Related]
2. PolyP and APC fight a RAGEing battle.
Mosnier LO
Blood; 2014 Feb; 123(6):804-6. PubMed ID: 24505066
[TBL] [Abstract][Full Text] [Related]
3. Inorganic Polyphosphate Amplifies High Mobility Group Box 1-Mediated Von Willebrand Factor Release and Platelet String Formation on Endothelial Cells.
Biswas I; Panicker SR; Cai X; Mehta-D'souza P; Rezaie AR
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1868-1877. PubMed ID: 29930000
[TBL] [Abstract][Full Text] [Related]
4. Inorganic polyphosphate: a key modulator of inflammation.
Hassanian SM; Avan A; Ardeshirylajimi A
J Thromb Haemost; 2017 Feb; 15(2):213-218. PubMed ID: 27925683
[TBL] [Abstract][Full Text] [Related]
5. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways.
Huang W; Liu Y; Li L; Zhang R; Liu W; Wu J; Mao E; Tang Y
Inflammation; 2012 Feb; 35(1):350-62. PubMed ID: 21494799
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
Lee W; Ku SK; Bae JW; Bae JS
Food Chem Toxicol; 2012 Jun; 50(6):1826-33. PubMed ID: 22429818
[TBL] [Abstract][Full Text] [Related]
8. Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice.
Chen X; Ma J; Kwan T; Stribos EGD; Messchendorp AL; Loh YW; Wang X; Paul M; Cunningham EC; Habib M; Alexander IE; Sharland AF; Chadban SJ; Wu H
Sci Rep; 2018 May; 8(1):8319. PubMed ID: 29844451
[TBL] [Abstract][Full Text] [Related]
9. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.
Qin YH; Dai SM; Tang GS; Zhang J; Ren D; Wang ZW; Shen Q
J Immunol; 2009 Nov; 183(10):6244-50. PubMed ID: 19890065
[TBL] [Abstract][Full Text] [Related]
10. Differential contribution of possible pattern-recognition receptors to advanced glycation end product-induced cellular responses in macrophage-like RAW264.7 cells.
Watanabe M; Toyomura T; Wake H; Liu K; Teshigawara K; Takahashi H; Nishibori M; Mori S
Biotechnol Appl Biochem; 2020 Mar; 67(2):265-272. PubMed ID: 31654427
[TBL] [Abstract][Full Text] [Related]
11. Indoprofen exerts a potent therapeutic effect against sepsis by alleviating high mobility group box 1-mediated inflammatory responses.
Bi X; Yan X; Jiang B; Liang J; Zhou J; Lu S; Liu J; Luo L; Yin Z
Toxicol Appl Pharmacol; 2021 Dec; 433():115778. PubMed ID: 34755645
[TBL] [Abstract][Full Text] [Related]
12. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.
Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S
Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells.
Ojo OO; Ryu MH; Jha A; Unruh H; Halayko AJ
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1354-66. PubMed ID: 26432865
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
15. High mobility group box 1 protein interacts with multiple Toll-like receptors.
Park JS; Gamboni-Robertson F; He Q; Svetkauskaite D; Kim JY; Strassheim D; Sohn JW; Yamada S; Maruyama I; Banerjee A; Ishizaka A; Abraham E
Am J Physiol Cell Physiol; 2006 Mar; 290(3):C917-24. PubMed ID: 16267105
[TBL] [Abstract][Full Text] [Related]
16. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.
van Zoelen MA; Yang H; Florquin S; Meijers JC; Akira S; Arnold B; Nawroth PP; Bierhaus A; Tracey KJ; van der Poll T
Shock; 2009 Mar; 31(3):280-4. PubMed ID: 19218854
[TBL] [Abstract][Full Text] [Related]
17. High Mobility Group Box Protein 1 Boosts Endothelial Albumin Transcytosis through the RAGE/Src/Caveolin-1 Pathway.
Shang D; Peng T; Gou S; Li Y; Wu H; Wang C; Yang Z
Sci Rep; 2016 Aug; 6():32180. PubMed ID: 27572515
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of high-mobility group box-1 protein 1 (HMGB1)/toll-like receptor (TLR) 4 with nasal interleukins in allergic rhinitis patients.
Zhu X; Cong J; Yang B; Sun Y
Cytokine; 2020 Feb; 126():154880. PubMed ID: 31739216
[TBL] [Abstract][Full Text] [Related]
19. The Immune Tolerance Role of the HMGB1-RAGE Axis.
Watanabe H; Son M
Cells; 2021 Mar; 10(3):. PubMed ID: 33807604
[TBL] [Abstract][Full Text] [Related]
20. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
